50 related articles for article (PubMed ID: 9042198)
1. Analysis of proliferative activity using Ki-67 on cervical precancerous lesions and the relationship to p53 expression.
Dellas A; Schultheiss E; Oberholzer M; Torhorst J; Gudat F
Anticancer Res; 1996; 16(6B):3403-7. PubMed ID: 9042198
[TBL] [Abstract][Full Text] [Related]
2. Combined p53 and retinoblastoma protein detection identifies persistent and regressive cervical high-grade squamous intraepithelial lesions.
Baak JP; Kruse AJ; Garland SM; Skaland I; Janssen EA; Tabrizi S; Fagerheim S; Robboy S; Nilsen ST
Am J Surg Pathol; 2005 Aug; 29(8):1062-6. PubMed ID: 16006801
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between human papilloma virus infection in cervical lesions and expression of p53, p21 proteins and Ki-67].
Horikoshi M; Kina K; Ishi K; Izumi H; Kunii Y; Nojima M
Rinsho Byori; 2005 Jun; 53(6):494-8. PubMed ID: 16026074
[TBL] [Abstract][Full Text] [Related]
4. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
5. P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia.
Walts AE; Lechago J; Bose S
Am J Surg Pathol; 2006 Jul; 30(7):795-801. PubMed ID: 16819320
[TBL] [Abstract][Full Text] [Related]
6. Development and assessment of a general theory of cervical carcinogenesis utilizing a severe combined immunodeficiency murine-human xenograft model.
Tewari KS; Taylor JA; Liao SY; DiSaia PJ; Burger RA; Monk BJ; Hughes CC; Villarreal LP
Gynecol Oncol; 2000 Apr; 77(1):137-48. PubMed ID: 10739703
[TBL] [Abstract][Full Text] [Related]
7. Markers of malignant transformation of sinonasal inverted papilloma.
Katori H; Nozawa A; Tsukuda M
Eur J Surg Oncol; 2005 Oct; 31(8):905-11. PubMed ID: 16005600
[TBL] [Abstract][Full Text] [Related]
8. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma.
Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S
J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU
Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271
[TBL] [Abstract][Full Text] [Related]
10. Biological features of bronchial squamous dysplasia followed up by autofluorescence bronchoscopy.
Hoshino H; Shibuya K; Chiyo M; Iyoda A; Yoshida S; Sekine Y; Iizasa T; Saitoh Y; Baba M; Hiroshima K; Ohwada H; Fujisawa T
Lung Cancer; 2004 Nov; 46(2):187-96. PubMed ID: 15474667
[TBL] [Abstract][Full Text] [Related]
11. Different proliferative patterns characterize different preinvasive breast lesions.
Viacava P; Naccarato AG; Bevilacqua G
J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of CK20, p53, and Ki-67 as objective markers of urothelial dysplasia.
Mallofré C; Castillo M; Morente V; Solé M
Mod Pathol; 2003 Mar; 16(3):187-91. PubMed ID: 12640096
[TBL] [Abstract][Full Text] [Related]
13. Proliferative activity (Ki-67), WT p53, Bcl-2 expression and their relationship to the tumor grade, in invasive ductal breast carcinomas.
Kalogeraki A; Garbagnati F; Santinami M; Zoras O
In Vivo; 2002; 16(2):141-4. PubMed ID: 12073773
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
15. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus (HPV) and p53 immunostaining in advanced tonsillar carcinoma--relation to radiotherapy response and survival.
Friesland S; Mellin H; Munck-Wikland E; Nilsson A; Lindholm J; Dalianis T; Lewensohn R
Anticancer Res; 2001; 21(1B):529-34. PubMed ID: 11299799
[TBL] [Abstract][Full Text] [Related]
17. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
18. An immunohistochemical analysis of heat shock protein 70, p53, and estrogen receptor status in carcinoma of the uterine cervix.
Park CS; Joo IS; Song SY; Kim DS; Bae DS; Lee JH
Gynecol Oncol; 1999 Jul; 74(1):53-60. PubMed ID: 10385551
[TBL] [Abstract][Full Text] [Related]
19. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy.
Cheng L; Sebo TJ; Cheville JC; Pisansky TM; Slezak J; Bergstralh EJ; Pacelli A; Neumann RM; Zincke H; Bostwick DG
Cancer; 1999 Mar; 85(6):1293-9. PubMed ID: 10189134
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 antigen and P53 protein expression in benign and malignant prostatic lesions. Immunohistochemical quantitative study.
Sasor A; Wagrowska-Danilewicz M; Danilewicz M
Pol J Pathol; 2000; 51(1):31-6. PubMed ID: 10833901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
